Marker Therapeutics logo
Marker Therapeutics MRKR
$ 3.78 1.34%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Marker Therapeutics Operating Cash Flow 2011-2024 | MRKR

Annual Operating Cash Flow Marker Therapeutics

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-27 M -27.3 M -20 M -18.3 M -14.5 M -8.44 M -6.51 M -4.34 M -2.19 M -695 K -1.59 M -1.31 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-695 K -27.3 M -11 M

Quarterly Operating Cash Flow Marker Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - -3.84 M - - - -5.89 M - -20.7 M -13 M -12.2 M - -22.4 M -14.9 M -8.1 M - -14.5 M -8.4 M -4.1 M - -13.7 M -8.06 M -3.88 M - -8.32 M -4.75 M -2.35 M - -5.96 M -3.94 M -1.92 M - -4.76 M - -830 K - - -1.83 M -1.01 M - -1.52 M -611 K -373 K - -755 K -620 K -17.5 M - -1.1 M -824 K -332 K - -877 K -735 K -404 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-332 K -22.4 M -5.97 M